- Home
- LTC vs BCRX Comparison
LTC vs BCRX Comparison
Compare LTC & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTC
- BCRX
- Stock Information
- Founded
- LTC 1992
- BCRX 1986
- Country
- LTC United States
- BCRX United States
- Employees
- LTC N/A
- BCRX N/A
- Industry
- LTC Real Estate Investment Trusts
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LTC Real Estate
- BCRX Health Care
- Exchange
- LTC Nasdaq
- BCRX Nasdaq
- Market Cap
- LTC 1.7B
- BCRX 1.7B
- IPO Year
- LTC 1992
- BCRX 1994
- Fundamental
- Price
- LTC $35.37
- BCRX $10.75
- Analyst Decision
- LTC Hold
- BCRX Buy
- Analyst Count
- LTC 5
- BCRX 8
- Target Price
- LTC $37.80
- BCRX $16.75
- AVG Volume (30 Days)
- LTC 344.6K
- BCRX 6.8M
- Earning Date
- LTC 05-05-2025
- BCRX 05-05-2025
- Dividend Yield
- LTC 6.44%
- BCRX N/A
- EPS Growth
- LTC 0.36
- BCRX N/A
- EPS
- LTC 1.93
- BCRX N/A
- Revenue
- LTC $202,686,000.00
- BCRX $503,485,000.00
- Revenue This Year
- LTC N/A
- BCRX $36.61
- Revenue Next Year
- LTC $4.41
- BCRX $13.19
- P/E Ratio
- LTC $18.33
- BCRX N/A
- Revenue Growth
- LTC 3.98
- BCRX 41.67
- 52 Week Low
- LTC $31.70
- BCRX $5.92
- 52 Week High
- LTC $39.89
- BCRX $11.11
- Technical
- Relative Strength Index (RSI)
- LTC 49.40
- BCRX 64.20
- Support Level
- LTC $34.97
- BCRX $10.46
- Resistance Level
- LTC $35.86
- BCRX $11.00
- Average True Range (ATR)
- LTC 0.56
- BCRX 0.41
- MACD
- LTC -0.05
- BCRX -0.02
- Stochastic Oscillator
- LTC 37.58
- BCRX 77.78
About LTC LTC Properties Inc.
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in seniors housing and healthcare facilities through mortgage loans, property lease transactions, and other investments. Its real estate investments includes different types of properties such as Independent living communities, Assisted living communities, Memory care communities, Skilled nursing centers and other types of properties.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.